‘Critical To Bring Back Domestic Manufacturing Of Key Essentials’ Insists Phlow CEO

Eric Edwards Bets On Continuous Manufacturing For Sustainable Supply Chain

01 Sep 2021

• By Akriti Seth

In an exclusive interview with Generics Bulletin, Phlow Corp CEO Eric Edwards has criticized the growing list of drug shortages in the US. He outlined the government-backed company’s objective of tackling drug shortages and supply chain vulnerabilities, to create a national stockpile of essential medicines.

“We need domestic manufacturing for key essential medicines in case of supply chain disruptions in the future,” Phlow CEO Eric Edwards has insisted, as he threw light on challenges faced by the US due to the COVID-19 pandemic in an exclusive interview with Generics Bulletin.

Phlow made headlines in May 2020 when the US government awarded federal government funding of $354m as part of a...